Literature DB >> 16807071

Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.

Di Sun1, Zhe Zhang, Do Nguyen Van, Guangwu Huang, Ingemar Ernberg, Lifu Hu.   

Abstract

CDH13 encodes a cell adhesion molecule, H-cadherin. In this study, we examined CDH13 methylation in nasopharyngeal carcinoma (NPC). Methylation specific PCR results showed that CDH13 was methylated in 20% (1/5) NPC cell lines, 100% (2/2) NPC xenografts and 89.7% (52/58) of the NPC primary tumors, while only methylated in 10% (1/10) normal nasopharyngeal epithelia (P<0.05). CDH13 expression in NPC cell lines and NPC xenografts analyzed by RT-PCR showed that expressions of CDH13 were reversely correlated with their methylation status. In CDH13-silenced cell line, demethylating agent 5-aza-deoxycytidine could dramatically restore CDH13 expression. Taken together, CDH13 promoter is aberrantly methylated in NPC both in vitro and in vivo, and promoter methylation plays a pivotal role in the silencing of H-cadherin expression. Furthermore, the high sensitivity (81%) and specificity (0% false positives) of detecting CDH13 methylation from nasopharyngeal swabs suggest it could be utilized as a tool for early diagnosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807071     DOI: 10.1016/j.oraloncology.2006.01.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  28 in total

1.  Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.

Authors:  Rob Noorlag; Pauline M W van Kempen; Cathy B Moelans; Rick de Jong; Laura E R Blok; Ronald Koole; Wilko Grolman; Paul J van Diest; Robert J J van Es; Stefan M Willems
Journal:  Epigenetics       Date:  2014-07-08       Impact factor: 4.528

2.  Aberrant TIG1 methylation associated with its decreased expression and clinicopathological significance in hepatocellular carcinoma.

Authors:  Xi-Hua Chen; Wen-Guang Wu; Jian Ding
Journal:  Tumour Biol       Date:  2013-09-05

3.  Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.

Authors:  Yanjie You; Wenjun Yang; Zhizhong Wang; Huimin Zhu; Haijun Li; Canfeng Lin; Yonggang Ran
Journal:  Cell Oncol (Dordr)       Date:  2013-06-06       Impact factor: 6.730

4.  Clinical significance of RECK promoter methylation in pancreatic ductal adenocarcinoma.

Authors:  Xiong-Xiong Lu; Shu-Min Zhang; Yuan Fang; Zheng-Ting Wang; Jun-Jie Xie; Qian Zhan; Xia-Xing Deng; Hao Chen; Jia-Bin Jin; Cheng-Hong Peng; Hong-Wei Li; Bai-Yong Shen
Journal:  Tumour Biol       Date:  2013-06-08

5.  Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics.

Authors:  Mohsen Karimi Arzenani; Atosa Esteki Zade; Yu Ming; Susanne J H Vijverberg; Zhe Zhang; Zahidul Khan; Syed Sadique; Lorenz Kallenbach; LiFu Hu; Vladana Vukojević; Tomas J Ekström
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

6.  Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.

Authors:  Yan-Jie You; Yu-Ping Chen; Xiao-Xuan Zheng; Stephen J Meltzer; Hao Zhang
Journal:  Cancer Lett       Date:  2011-09-12       Impact factor: 8.679

7.  Aberrant Methylation of T-cadherin Can Be a Diagnostic Biomarker for Colorectal Cancer.

Authors:  Bo-Shi Duan; Long-Fei Xie; Yue Wang
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

Review 8.  Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease.

Authors:  Tamotsu Takeuchi; Yoshihiro Adachi; Yuji Ohtsuki; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

9.  DLC-1 is a candidate biomarker methylated and down-regulated in pancreatic ductal adenocarcinoma.

Authors:  Yu-Zheng Xue; Tie-Long Wu; Yan-Min Wu; Ying-Yue Sheng; Zhe-Qiang Wei; Yu-Feng Lu; Li-Hua Yu; Jian-Ping Li; Zhao-Shen Li
Journal:  Tumour Biol       Date:  2013-05-17

10.  Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia.

Authors:  Kyung-Ok Uhm; Eun Soo Lee; Yun Mi Lee; Jeong Seon Park; Seok Jin Kim; Byung Soo Kim; Hyeon Soo Kim; Sun-Hwa Park
Journal:  J Korean Med Sci       Date:  2009-06-18       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.